Table 3.

Cox analysis of OS in solid cancer patients

CovariablesOR95% CIP
Tumor type (Mel, Bla, and Ova)2.0311.387–2.9730.000
Tumor staginga4.9191.941–12.4630.001
NK cell CD226 (MFI) > 7,3850.2410.120–0.4860.000
  • OR, odd ratio; 95% CI, 95% confidence interval; Mel: melanoma; Bla: bladder; Ova: ovarian.

  • aEstimated as tumor staging for melanoma (Breslow depth > or <1 mm), bladder cancer (superficial vs. invasive), and ovarian carcinoma (staging I and II vs. III and IV).